The PassMachine Medical Oncology Board Review 2020 (v5.1) (Beattheboards) (Lectures)

Online Course v5.1: A Comprehensive Guide to Medical Oncology Education

Release Date: October 14, 2020

Termination Date: October 13, 2023

Course Overview:

This comprehensive online course provides an unparalleled learning experience for Medical Oncologists, guiding them through a comprehensive syllabus of topics curated to align precisely with the Medical Oncology Certification and MOC exam blueprints. The course features high-yield content and laser-focused lectures to ensure a thorough understanding of all essential exam topics and keywords.

Expert Faculty:

The course is led by a team of board-certified Medical Oncology faculty with extensive experience in teaching board exam preparation. Their expertise ensures that every lecture is medically accurate, up-to-date, and tailored to the specific needs of oncologists.

Comprehensive Course Syllabus:

The accompanying PDF syllabus provides a meticulously detailed overview of the course content, spanning hundreds of pages. It serves as an invaluable resource for participants, enabling them to navigate the material effectively and monitor their progress.

Targeted Learning Objectives:

Upon completion of this program, participants will be equipped to:

• Accurately assess diagnosis, staging, and prognostic factors of breast cancer
• Discuss the various types of gynecologic cancer
• Understand the pharmacological and biological principles in cancer management and treatment
• Develop comprehensive treatment plans for genitourinary cancers (including bladder, urothelial, prostate, renal, and germ cell tumors)
• Demonstrate proficiency in the medical management of lung and thymic cancer, as well as mesothelioma
• Integrate various modalities of care and ethics, including treatment-related issues, supportive care, survivorship, psychosocial aspects, and communication skills

Content Highlights:

• Hematologic Neoplasms:
  • Acute Leukemia and Myelodysplasia
  • Chronic Myeloid Leukemia and Myeloproliferative Neoplasms
  • Chronic Lymphoproliferative Leukemias
  • Multiple Myeloma and Plasma Cell Dyscrasias
  • Non-Hodgkin Lymphoma
• Thoracic Cancer:
  • Non-small Cell Lung Cancer
  • Small Cell Lung Cancer, Mesothelioma, and Thymus Cancer
• Breast Cancer:
  • Premalignant Conditions and Carcinoma in Situ
  • Early-Stage Invasive Carcinoma
  • Less Common Histologies
  • Locally Advanced, Inflammatory, and Locally Recurrent Disease
  • Metastatic Disease
• Genitourinary Cancer:
  • Germ Cell Tumors
  • Prostate Cancer
  • Renal Cell Cancer
  • Urothelial and Other Genitourinary Cancers
• Gynecologic Cancer:
  • Cancer of the Cervix, Vulva, Vagina, and Other Malignancies
  • Ovarian Cancer
• Gastrointestinal Cancer:
  • Pancreatic and Anal Cancer
  • Biliary/Gallbladder Cancer and Neuroendocrine Tumors
  • Colorectal Cancer
  • Gastric Cancer
  • Esophageal Cancer
  • Hepatocellular Carcinoma
• Skin Cancer, Sarcomas, and Unknown Primary Site:
  • Bone and Soft Tissue Sarcomas
  • Unknown Primary Site
  • Melanoma and Other Skin Cancers
• Anticancer Therapeutics, Clinical Research Methodology, and Ethics:
  • Anticancer Therapeutics
  • Clinical Research Methodology and Ethics
  • Principles of Allied Disciplines
• Palliative Care, Survivorship, and Communication:
  • Cancer Pain
  • Survivorship Issues
  • Clinical Manifestations of Advanced Cancer and Its Treatment
  • End-of-Life Issues
  • Procedure-related Issues and Communication
• Head, Neck, Thyroid, and Central Nervous System Malignancies:
  • Head and Neck Cancer
  • Thyroid and Salivary Gland Cancer
  • Central Nervous System Malignancies
• Genetics and Tumor Biology:
  • Cancer Biology, Genetics, and Tumor Immunology
  • Heritable Cancer Syndromes and Cancer Epidemiology